Oramed Pharmaceuticals (ORMP) Revenue (2016 - 2025)

Oramed Pharmaceuticals' (ORMP) quarterly Revenue came in at $2.0 million in Q1 2025, up 196.74% on a QoQ basis from $674000.0 in Q2 2023.

Oramed Pharmaceuticals (ORMP) Revenue (2016 - 2025) Analysis & Trends

Oramed Pharmaceuticals (ORMP) has 8 years of Revenue data on file, last reported at $2.0 million in Q1 2025.

Quarterly Revenue changed N/A year-over-year to $2.0 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $2.0 million, changed N/A from the prior year.
Revenue rose to $2.0 million in Q1 2025, from $674000.0 in the prior quarter.
In the past five years, Revenue ranged from a high of $2.7 million in Q3 2021 to a low of $666000.0 in Q1 2022.
A 4-year average of $1.1 million and a median of $678000.0 in 2022 frame the typical range for Revenue.
The widest YoY moves for Revenue: up 0.0% in 2023, down 0.0% in 2023.
Tracing ORMP's Revenue over 4 years: stood at $2.7 million in 2021, then tumbled by 66.56% to $904000.0 in 2022, then fell by 25.44% to $674000.0 in 2023, then surged by 196.74% to $2.0 million in 2025.
The last three Revenue figures came in at $2.0 million (Q1 2025), $674000.0 (Q2 2023), and $666000.0 (Q1 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	3.33 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	4.29 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	1.52 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	145.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	1.71 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	1.29 Bn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	425.49 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	674.14 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	1.06 Bn
10	Oramed Pharmaceuticals	196.17 Mn	196.17 Mn	-	-

Download Data